The bill amends sections 28-405 and 28-416 of the Revised Statutes Cumulative Supplement, 2024, as part of the Uniform Controlled Substances Act, by introducing new substances to the controlled substances schedules, particularly under Schedule I, which now includes various fentanyl analogs and synthetic opioids like Meta-Fluorofentanyl and Butonitazene, while deleting the entry for Brorphine. It also clarifies the definitions of peyote and psilocybin, specifying that psilocybin does not include any FDA-approved pharmaceutical compositions. The bill aims to keep the controlled substances schedules updated in response to emerging drug trends, particularly concerning synthetic opioids and hallucinogens, reflecting ongoing public health concerns related to substance abuse.

Additionally, the bill proposes new penalties for individuals aged eighteen years or younger who violate specific sections related to motor vehicle licenses and permits, establishing a tiered penalty system for offenses that includes license impoundment and mandatory drug education classes. For those without a permit or license, similar penalties apply, prohibiting them from obtaining a permit or license for specified periods. The bill also mandates that court convictions be reported to the Director of Motor Vehicles if a license is impounded or if a juvenile is prohibited from obtaining a license, while repealing the original sections 28-405 and 28-416. Overall, the bill seeks to enhance the regulation of controlled substances and address public health and safety concerns related to drug abuse and trafficking.

Statutes affected:
Introduced: 28-405, 28-416
Final Reading: 28-405, 28-416
Slip Law: 28-405, 28-416